November 2026

196 Articles

Clinical Insights

Commentary

Metabolic dysfunction associated chronic liver disease in Europe: much has to be done before we are really united

26 October 2026
Author(s): Agostino Di Ciaula, Anne M. van Dijk, Piero Portincasa, Karel J. van Erpecum

Metabolic dysfunction associated liver disease (MASLD) is the most common liver disease worldwide, and a leading cause of liver-related morbidity and mortality. Current prevalence is approximately 30... more

The Underused Metric: Non-HDL cholesterol in cardiometabolic care

28 September 2026
Author(s): Maurizio Averna

In this issue of the European Journal of Internal Medicine, Carlos Baeza-Delgado et al. present a compelling real-world analysis utilizing a large electronic health record database [1]. The study... more

Access, equity, and implementation: The unfinished agenda of cardiac rehabilitation

16 September 2026
Author(s): Andrea Passantino, Michele Vitacca

Cardiac rehabilitation (CR) is a comprehensive, multidisciplinary intervention that improves survival, reduces hospitalizations, enhances functional capacity, and increases health-related quality of... more

Beyond ejection fraction: Right ventricular dysfunction and cardio-hepatic involvement in heart failure with mildly reduced ejection fraction

12 September 2026
Author(s): Enrico Fabris, Gianfranco Sinagra

Left ventricular ejection fraction (LVEF) remains the principal parameter through which heart failure (HF) is classified, investigated, and treated. Yet, in heart failure with mildly reduced ejection... more

Hyponatremia among frail and elderly: still poorly managed, but at what cost?

24 August 2026
Author(s): Buster Mannheimer, Henrik Falhammar, Jakob Skov

Hyponatremia affects between 10% and 30% of hospitalized patients, making it by far the most common electrolyte disorder in clinical practice. Symptoms vary but often include confusion, nausea, and... more

Subclinical hypotension in acute decompensated heart failure: a warning signal, not a therapeutic barrier

24 August 2026
Author(s): Luis M. Pérez-Belmonte, Ricardo Gómez-Huelgas

Acute decompensated heart failure (ADHF) is characterized by marked clinical and hemodynamic heterogeneity, making the interpretation of blood pressure (BP) particularly challenging[1]. Low BP is... more

Fluid balance in critical illness: From arbitrary thresholds to outcome-linked stewardship

21 August 2026
Author(s): Carmine Zoccali, Francesca Mallamaci

Fluid therapy remains one of the most common, powerful, and potentially hazardous interventions in intensive care. For decades, clinicians have understood that both under-resuscitation and over-... more

Editorial

Promoting equity in academic medicine: a call for coordinated action across journals, healthcare organisations and professional societies

23 September 2026
Author(s): Francesca Rubulotta, Jordi Rello, Joan B Soriano, Vojislava Neskovic

The recent paper by Hamzaoui et al. in the European Journal of Internal Medicine makes an important, timely case for targeted interventions to promote women’s careers in life sciences and medicine [1... more

P‑values aren’t the problem - 0.05 and our interpretation are. The 7 deadly sins that distort health research

7 August 2026
Author(s): Edward James Watts

Randomness describes non-deterministic events and is measured through probability. A Galton board illustrates this. Each pin represents a 50/50 chance of moving left or right, like repeated coin... more

When the prescribing of medications triggers a diagnostic cascade

19 July 2026
Author(s): Graziano Onder, Jerry H. Gurwitz, Joyce Li, Paula A. Rochon

Prescribing cascades are traditionally defined as a sequence in which an adverse effect of a medication is misinterpreted as a new medical condition, leading to the prescription of additional... more

Ideas and Opinions

Targeting the kidney-gut axis in chronic kidney disease: From biological insight to therapeutic opportunity

14 July 2026
Author(s): Domenico Bagordo, Giovanni Santacroce, Giorgia Adiutori, Federica Biasi, Maria Vittoria Parola, Antonio Di Sabatino

Chronic kidney disease (CKD) is increasingly recognized as a systemic disorder characterized by complex metabolic, inflammatory, and cardiovascular interactions [1]. Beyond the progressive decline in... more

Internal Medicine Flashcard

Blurred vision and acute confusion in a young woman: what is the diagnosis?

15 October 2026
Author(s): Eduard Pedemonte-Sarrias, Marta Saint-Gerons

A previously healthy woman in her late 30 s presented with blurred vision in the right eye and an acute confusional state. Five months earlier she had experienced a self-limited right sixth-nerve... more

Blood-filled colonic blebs in a patient with abdominal pain and hematochezia

15 October 2026
Author(s): Minmin Fan, Xiangji Li, Tian He

An elderly anuric man receiving maintenance haemodialysis was admitted with a 10-day history of abdominal pain and distension, followed by recurrent haematochezia. His haemoglobin concentration... more

Left ventricle echocardiographic “spade-like” configuration

15 September 2026
Author(s): Liliana Estefania Ramos Villalobos, Daniela Saraí León Pérez, Pavel Alejandro Chávez Márquez, Oscar Rene González Hernández

Editor - in - Chief

Reverse Fitz-Hugh–Curtis syndrome

21 August 2026
Author(s): Sho Koshikizawa, Kosuke Ishizuka, Shintaro Kosaka

A 40-year-old woman presented with left lower abdominal pain that had begun 2 days earlier and subsequently shifted to the left hypochondrium. The pain was persistent, worsened with deep inspiration... more

Disseminating subcutaneous nodules without systemic symptoms in an elderly man

16 August 2026
Author(s): Mika Watanabe, Chihiro Shiiya, Hiroko Gotoda

A man in his 90 s presented with a 1-month history of more than ten 1–2-cm, elastic-hard, mildly bluish subcutaneous nodules distributed across the chest, abdomen, and thighs, without associated pain... more

When blood doesn’t flow: a 21-year-old man with recurrent arthralgia and muscle soreness

10 August 2026
Author(s): M.A González Fernández, H Calderón Álvarez, I Salguero Rodríguez

A 21-year-old patient presented with intermittent episodes of myalgia, arthralgia, and bone pain in the extremities and spine, triggered by physical exertion and dating back 9 years. The patient had... more

A flower blooming in the Lung

10 August 2026
Author(s): Annarita Botta, Rossella Filippelli, Roberto Parrella

A 63-year-old Italian woman was referred to our outpatient pulmonology clinic with a three-month history of productive cough associated with yellowish, flake-like sputum and profound asthenia. She... more

Opportunistic infections in a patient with T-cell lymphocytopenia of unclear cause

16 June 2026
Author(s): Sabrina Belhabib, David Boutboul, Claude Bachmeyer

A 57-year-old Moroccan woman with no relevant personal and family history presented with a 2 month history of progressive loss of vision of the left eye. Vital signs were normal. Ophthalmologic... more

Invited Review Article

Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors

24 September 2026
Author(s): Kaitlin J Mayne, Matthew M Y Lee, Naveed Sattar, William G Herrington

The definition, epidemiology and pathophysiology of the cardiovascular-kidney-metabolic (CKM) syndrome are detailed in the preceding articles in this collection. For many years risk-modifying therapy... more

Artificial intelligence in medicine: An ethical and legal review

26 August 2026
Author(s): Sebastian Schleidgen, Orsolya Friedrich

The integration of artificial intelligence (AI) and machine learning (ML) into medical practice marks a transformative shift within healthcare delivery, diagnostics, and treatment paradigms. Although... more

Artificial intelligence in diagnostics and medical decision making

4 July 2026
Author(s): Marcel Levi

Artificial intelligence (AI) applications bear a great promise for healthcare. If successfully implemented, AI could reduce the workload for healthcare professionals and enhance the quality of work... more

Letter to the Editor

Accounting for time in infections and outcomes of ANCA-associated vasculitis

31 October 2026
Author(s): Mengna Li, Haoyuan Liu, Huanhuan Liu

We read with interest the study by Morin et al. describing infectious complications and long-term outcomes in ANCA-associated vasculitis (AAV) [1]. Their findings underscore the value of continued... more

Hypertonic saline in acute heart failure: Caution in interpreting real-world evidence

29 October 2026
Author(s): Jian-xin Li, Pei-pei Zhang

We read with great interest the study by Ropero-Luis et al. [1].published in the European Journal of Internal Medicine, on the real-world use of hypertonic saline solution combined with high-dose... more

Urinary calcium excretion as a potential biomarker of diuretic resistance in heart failure

29 October 2026
Author(s): Joan Carles Trullàs, Ignacio Giménez-López, Elena Zueras-Escanilla, Wendy McCallum, Jorge Rubio-Gracia

Loop diuretic resistance (DR) is a major challenge in acute heart failure (HF) hindering adequate decongestion. DR is partly driven by distal convoluted tubule (DCT) remodelling and enhanced sodium... more

Thromboembolic risk associated with desmopressin use in patients with central diabetes insipidus

27 October 2026
Author(s): Cheng-Hao Kuo, I-Wei Ho, Chun-Ying Wu, Tsai-Wei Huang, Chin-Chou Huang

Central diabetes insipidus (DI), now formally termed arginine vasopressin deficiency (AVP-D) [1], is a rare endocrine disorder characterized by insufficient secretion of arginine vasopressin (AVP),... more

Defining sustained treatment benefit in low-renin hypertension with adrenal incidentalomas

26 October 2026
Author(s): Jing Zhao, Yonggang Dai

Uslar and colleagues show how an incidental adrenal adenoma can prompt a useful reassessment of hypertension [1]. Their prospective cohort identified suppressed renin in 138 of 290 patients, and... more

Contextualizing the economic and survival benefits of daily home haemodialysis: A critical appraisal. Author's reply

26 October 2026
Author(s): Guy Rostoker, Jean-Jacques Dumas, Benoît Thomé, Michel Thomas, Bernard Canaud

We read with great interest the Letter to the Editor by Miduturu Sukumar and Kabilan Annadurai [1], submitted to our article recently published in the European Journal of Internal Medicine (EJIM) [2... more

Contextualizing the economic and survival benefits of daily home haemodialysis: A critical appraisal

26 October 2026
Author(s): Miduturu Sukumar, Kabilan Annaduraai

We read with great interest the recent article by Rostoker et al. [1] evaluating the cost-effectiveness of daily home haemodialysis compared with conventional in-centre haemodialysis using real-world... more

The changing long-term clinical course of deep vein thrombosis in the direct oral anticoagulant era

22 October 2026
Author(s): Paolo Prandoni, Sofia Barbar, Giuseppe Camporese, Beniamino Zalunardo, Franco Noventa, DOAC-DVT Investigators

Dear Editor,

Residual vulnerability after decompensated heart failure: what remains unmet after the 2026 ESC guidelines for the management of heart failure?

22 October 2026
Author(s): Angelina Borizanova, Elena Kinova, Assen Goudev

The 2026 European Society of Cardiology (ESC) Guidelinеs for the management of heart failure (HF) introduce several important changes [1]. First, they return to two types based on left ventricular... more

Depressive symptoms in older patients with atrial fibrillation: From clinical phenotype to targeted intervention

21 October 2026
Author(s): Aamer Aldbyani

Fumagalli et al. [1] examined depressive symptoms in older patients undergoing electrical cardioversion for persistent atrial fibrillation (AF) and identified associations with clinical complexity... more

Beyond the ApoB/ApoA1 ratio: divergent apolipoprotein trajectories after sleeve gastrectomy

18 October 2026
Author(s): Federica Fogacci, Federica Perazza, Alessandro Ciocia, Arrigo F.G. Cicero

To the Editor,

Central pulmonary emboli: from prognostic association to clinical utility

18 October 2026
Author(s): Qing Yi, Kaifeng Han

Vedovati and colleagues provide a timely analysis of central embolic localization in acute pulmonary embolism (PE) using the large, multicentre Contemporary Management of Acute Pulmonary Embolism (... more

Abatacept in RA-ILD: further clarification of the potential pulmonary window of opportunity

17 October 2026
Author(s): Ana Serrano-Combarro, Adrián Martín-Gutiérrez, Belén Atienza-Mateo, Ricardo Blanco

Dear Editor,

Polycythemia after SGLT2 inhibition: A post-treatment state, not a baseline subgroup

17 October 2026
Author(s): Jiaqi Shen, Fangfang Huang

We read with interest the pooled analysis by Marques and colleagues examining polycythemia and cardiovascular outcomes across five randomized trials of sodium-glucose cotransporter 2 inhibitors (... more

Study selection and translational NNTs in severe asthma and COPD: methodological considerations

16 October 2026
Author(s): Gde Bagus Susila Pradnyana Nurcahyo Oka, I Komang Rizky Kesatria Hary Putra, Ni Luh Putu Queena Patria Witama, Evan Nathan Sucita

Dear Editor,

Mediterranean diet adherence and sleep quality in polyendocrine metabolic ovarian syndrome: association or independent predictor? Author's reply

16 October 2026
Author(s): Ludovica Verde, Martina Galasso, Annamaria Colao, Luigi Barrea, Giovanna Muscogiuri

We would like to thank Hussain for taking the time to reflect on our paper [1,2]. His comment raised some points of great interest.

Interpreting the neutrophil-to-lymphocyte ratio in stable chronic obstructive pulmonary disease: severity, case mix, and clinical utility. Author's reply

12 October 2026
Author(s): Marco Vanetti, Antonio Spanevello

We thank Zhang and colleagues for their thoughtful comments on our study and for the opportunity to further clarify the interpretation and clinical implications of our findings [1].

Pulmonary artery diameter and sudden death in PAH. Is 40 mm a true threshold or a warning value? Author’s reply

8 October 2026
Author(s): Federico Donato, Massimiliano Palazzini, Elena Nardi, Alessandra Manes, Fabio Dardi

Dear Editor,

Obesity care in internal medicine: A gap between recognition and treatment competence

6 October 2026
Author(s): Nursel Calik Basaran, Fatma Yalcinkaya, Oguz Abdullah Uyaroglu, Serhat Ünal

Dear Editor,

Infarction or injury? Diagnostic labeling and coronary angiography after troponin elevation

5 October 2026
Author(s): Belal Mohamed Hamed, Karim Atta, Ahmed Emara, Moaz Elsayed Abouelmagd, Yasar Sattar

Dear Editor,

Early C-reactive protein change and mortality in emergency admissions: a trajectory, not a target

3 October 2026
Author(s): Satoshi Kutsuna, Shungo Yamamoto, Ryuichi Minoda Sada

Internists repeat C-reactive protein a few days after an emergency admission almost as a reflex, and many of us act on the second value: a fall reassures, a rise prompts a rethink. Yet the evidence... more

LDL cholesterol lowering before a first cardiovascular event: interpreting relative efficacy through absolute risk

1 October 2026
Author(s): Francisco Epelde Gonzalo, María Pilar Martínez López

Low-density lipoprotein cholesterol (LDL-C) lowering before a first cardiovascular event is often discussed as if “primary prevention” were a single clinical setting. It is not. The term includes... more

Orthostatic hypotension in heart failure: Prevalence as a first step for future research

1 October 2026
Author(s): Federica Coscetta, Alberto M. Marra

We were pleased to read the commentary by Shen et al. [1] dwelling upon our work that investigated the prevalence of orthostatic hypotension (OH) in patients with heart failure (HF) [2]. Their letter... more

Conflicting health information and skepticism toward clinical trials among U.S. adults

28 September 2026
Author(s): Chinenye Lynette Ejezie, Chengcheng Zhang, Sarah E. Messiah

Dear Editor,

The sepsis paradox in 2026: defining dysregulation, treating the syndrome

26 September 2026
Author(s): Miguel Morante-Ruiz, Javier Camacho-Mateu, Carmen Álvaro-Vegue, Fernando Tornero-Romero

Dear Editor,

Limited incremental value of metabolic and inflammatory profiling for arterial stiffness beyond anthropometry: data from the Brisighella Heart Study

21 September 2026
Author(s): Arrigo F.G. Cicero, Sergio D’Addato, Alessandro Ciocia, Claudio Borghi, Federica Fogacci, Brisighella Heart Study Group

Carotid-femoral pulse wave velocity (PWV) is the reference non-invasive measure of aortic stiffness and provides prognostic information beyond conventional cardiovascular risk factors [1,2]. Obesity... more

Quality Matters after acute myocardial infarction: making LDL-C risk visible, actionable, and accountable

21 September 2026
Author(s): Felice Gragnano, Sergio Leonardi

We thank Wang and Ge for their comments [1] and interest in our multicentre Quality Matters audit [2]. Their letter usefully extends the discussion from the description of low-density lipoprotein... more

Obstructive sleep apnea as an important modifier of cardiovascular-kidney-liver-metabolic syndrome (CKLMS)

19 September 2026
Author(s): Reinhold Kreutz, Ali Canbay, Andrzej Januszewicz

obstructive sleep apnea (OSA) is increasingly recognized as a determinant of cardiometabolic health, and intersects with hypertension, metabolic dysfunction, and cardiorenal disease [1]. Its... more

Fast-tracking internal medicine: An American debate with European implications

12 September 2026
Author(s): Oğuz Abdullah Uyaroğlu

A recent New England Journal of Medicine Clinical Decisions article asked whether selected internal medicine residents in the United States should be allowed to enter subspecialty fellowship after 2... more

Interpreting diagnosis-specific hospitalisation after atrial fibrillation screening: Diagnostic attribution and time origin

11 September 2026
Author(s): Xin Gan, Zhicheng Huang

We read with interest the study by Kongebro and colleagues examining long-term healthcare utilisation after atrial fibrillation (AF) screening in the LOOP study [1]. The study provides valuable... more

Interpreting the role of biological sex in adults with candidemia: beyond mortality prediction

11 September 2026
Author(s): Claudia BARTALUCCI, Giusy TISEO, Marco MUCCIO, Antonio VENA

Dear Editor,

Timely allopurinol in asymptomatic hyperuricemia: modelling a hypothesis worth prospective investigation. Authors’ reply

9 September 2026
Author(s): András Inotai, Dávid Nagy, Gábor Kovács, Claudio Borghi

We thank Liu and Jin for their thoughtful comments on our study [1,2]. We agree that the modelled cardiovascular and renal outcomes should be interpreted cautiously and conditionally on the... more

Unmasking the hidden burden of stroke-heart syndrome through phenotype-informed risk stratification

8 September 2026
Author(s): Menglong Li

I read with great interest the article by Rigutini and colleagues regarding all-cause mortality and early cardiovascular complications in relation to lesion location and stroke subtype in the Perugia... more

Preclinical coronary artery disease: From early detection to cardiovascular prevention

8 September 2026
Author(s): Andrea Rubboli, Roxana Mehran, Pascal Vranckx, Dominick J. Angiolillo

Dear Editor,

From ECOG performance status to bedside anticoagulation decisions in cancer-associated thrombosis

8 September 2026
Author(s): Surui Yuan, Lingshuang Liu

We read with great interest the multicenter cohort study by Talerico et al. examining the association between Eastern Cooperative Oncology Group performance status and clinical outcomes in patients... more

Association between air pollution and preeclampsia: a nationwide study from 2018 to 2023

8 September 2026
Author(s): Nhi Truong, Mathieu Fortier, Lucas Léger, Chris Serrand, Sylvie Bouvier

Preeclampsia (PE) represents a major cause of maternal morbidity and mortality worldwide, and a risk factor for future maternal cardiovascular disease [1]. Therefore, there is a crucial need to... more

Andes hantavirus in children: extending clinical recognition across age groups

7 September 2026
Author(s): Weerapong Lilitwat, Yuttiwat Vorakunthada

To the Editor,

Aligning exposure and outcome clocks in fluid-balance research

7 September 2026
Author(s): Jiaqi Shen, Fangfang Huang

Dear Editor,

Beyond TSH and FT4: reconsidering thyroid hormone dynamics in metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus

6 September 2026
Author(s): Claudia Leanza, Rossella Cannarella, Andrea Crafa, Federica Barbagallo, Aldo E. Calogero

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and is particularly prevalent among patients with type 2 diabetes mellitus (T2DM) [... more

Sex differences in candida bloodstream infection: Beyond 30-day mortality

2 September 2026
Author(s): Ji Li

I have read with great interest the recent multicentre study by Bartalucci et al. investigating sex-based differences and clinical outcomes among older adults with Candida bloodstream infection (C-... more

Deprescribing after hypotensive syncope: Recurrence burden and ambulatory blood pressure targets

1 September 2026
Author(s): Sevval Altay

The multicentre, prospective study by Russo et al. [1] evaluated a deprescribing strategy supported by ambulatory blood pressure monitoring in 92 hypertensive patients with severe hypotensive syncope... more

Urinary albumin-to-creatinine ratio in heart failure: Methodological and clinical considerations

31 August 2026
Author(s): Can Lu, Jun Guo

We read with great interest the study by Rubio-Gracia J et al., which evaluated the prognostic significance of the urinary albumin-to-creatinine ratio (UACR) in the RICA-2 heart failure (HF) registry... more

Prurigo nodularis: time to look beyond the skin—towards cardiovascular and metabolic comorbidity

31 August 2026
Author(s): Inês Tribolet de Abreu, Paulo Filipe

Prurigo nodularis (PN) is increasingly recognised as a systemic disease marker rather than an isolated dermatological disorder. Although the dominant clinical manifestation is chronic, often severe... more

Early allopurinol in asymptomatic hyperuricemia: caution in interpreting modelled cardiorenal benefits

29 August 2026
Author(s): Cong Liu, Chengqiang Jin

We read the article by Inotai et al. with interest [1]. Whether allopurinol should be started before the first gout flare is a practical question, especially in people already at high cardiovascular... more

Malnutrition predicts adverse clinical outcomes in older patients hospitalized in internal medicine wards

28 August 2026
Author(s): Carlotta Franchi, Sara Mandelli, Alessandro Nobili, Pier Mannuccio Mannucci, Ilaria Ardoino, REPOSI Investigators

Dear Editor, malnutrition is a frequent but often overlooked condition among hospitalized older adults that substantially affects their prognosis [1,2]. Patients admitted to internal medicine wards... more

Can device-derived digital biomarkers detect physiological response to SGLT2 inhibition in heart failure?

27 August 2026
Author(s): Ursula Rohrer, Katharina Ingrid Gölly, Markus Stühlinger, Dirk von Lewinski, Daniel Scherr, for the ERASe study group

Heart failure (HF) remains a leading cause of morbidity and mortality despite substantial advances in guideline-directed medical therapy [1]. Alongside therapeutic developments, cardiac implantable... more

Orthostatic hypotension in heart failure: Moving from prevalence to phenotype

24 August 2026
Author(s): Jiaqi Shen, Zhichao Zhao, Ting Shen, Fangfang Huang

To the Editor Coscetta and colleagues provide the first systematic estimate of orthostatic hypotension (OH) in patients with heart failure (HF), pooling nine studies (10 cohorts; 2036 patients) and... more

Protein supplementation and diaphragmatic function in hospitalized older adults

20 August 2026
Author(s): Fábio C. de Assis, Saulo Gil, Priscila Vieira Loureço dos Reis, Luciano F. Drager, Alexandre Anderson de Souza Munhoz Soares

Acute hospitalization accelerates muscle loss in older adults through inflammation, immobility, inadequate nutritional intake, and anabolic resistance. Respiratory muscles may also be affected,... more

Should LDL cholesterol targets be individualized according to bleeding risk?

13 August 2026
Author(s): Carmine Siniscalchi

The recently published Ez-PAVE trial has further consolidated one of the fundamental principles of cardiovascular prevention by demonstrating that an intensive low-density lipoprotein cholesterol (... more

Pulmonary artery diameter and sudden death in PAH: Is 40 mm a true threshold or a warning value?

10 August 2026
Author(s): Hongquan Xing, Xiaoqun Ye

We read with great interest the study by Dardi and colleagues investigating the haemodynamic determinants and prognostic implications of pulmonary artery dilation in pulmonary arterial hypertension (... more

Comparable 1-year effectiveness of tezepelumab and dupilumab after anti–IL-5/IL-5Rα biologic failure in severe asthma

8 August 2026
Author(s): Po-Cheng Shih, Shih-Pin Chen, James Cheng-Chung Wei

Since 2003, multiple biologics targeting specific inflammatory pathways have been developed for severe asthma. Despite guideline-recommended selection based on clinical characteristics and biomarkers... more

Serum uric acid trajectories in women: Why elevated levels in younger women warrant attention

8 August 2026
Author(s): Anna Vittoria Mattioli, Claudio Borghi

Serum uric acid (SUA) is usually interpreted as a single measurement against a fixed threshold. In women, however, this static approach may be particularly misleading. SUA follows a dynamic course... more

Hemodynamic renal adaptation, cardiorenal pharmacotherapy, and the case for structured monitoring in HFrEF

6 August 2026
Author(s): Shanti Bhushan Mishra

We read with great interest the reply by Russo et al. [1], in which the authors addressed comments on their review of renal protection strategies in heart failure with reduced ejection fraction (... more

Clarifying the lipid signal: non-HDL cholesterol, remnant cholesterol and metabolic risk in primary care

3 August 2026
Author(s): Fuad A. Abdu

I read with great interest the study by Baeza-Delgado et al. [1], which assessed the prevalence of elevated non-high-density lipoprotein cholesterol (non-HDL-C) in 820,318 individuals not receiving... more

Candida bloodstream infection in older adults: sex as a pathway marker, not a mortality shortcut

28 July 2026
Author(s): Zhichao Zhao, Ting Shen

We read with great interest the multicentre analysis by Bartalucci and colleagues, who evaluated sex-based differences and 30-day mortality in 1132 adults aged 65 years or older with Candida... more

Abatacept in RA-ILD: defining rather than assuming a pulmonary window of opportunity

27 July 2026
Author(s): Shuting Kong, Kepeng Yang

We read with great interest the multicentre study by Serrano-Combarro and colleagues evaluating abatacept in rheumatoid arthritis-associated interstitial lung disease (RA-ILD). The authors should be... more

Factor XIa inhibitors after acute non-cardioembolic ischemic stroke or high-risk TIA

25 July 2026
Author(s): Ahmed Emara, Ahmed Mansour, Ameer Awashra, Ahmed Adel Abdel Azim, Abdalhakim Shubietah

Dear Editor,

Retatrutide and the urinary tract infection signal: Is the answer hidden in timing?

23 July 2026
Author(s): Theocharis Koufakis, Georgia Argyrakopoulou, Alexander Kokkinos, Carel W. le Roux

Dear editor,

Persistent hyponatremia at discharge: Undertreatment or unresolved diagnosis?

23 July 2026
Author(s): Enmanuel A. Leiva-Murillo, Carles Cebrián i Jerónimo, Marina Gregori-Jonama, Karamjot Singh-Kaur

Dear Editor,

Beyond fixed BMI cutoffs after paroxysmal atrial fibrillation ablation

23 July 2026
Author(s): Ying Huang, Hongping Wang, Yanzheng Song, Xiaochun Han, Liangqing Guo

Dear Editor,

The missing piece in severe acquired brain injury care: Integrating neurophysiological screening for critical illness polyneuropathy and myopathy. Author’s reply

21 July 2026
Author(s): Camilla Grifoni, Angela Comanducci, Luca Bucciardini

We thank Messina for his insightful comments on our recent article describing a novel Neuro-ICU-Neurorehabilitation Unit (INRU) co-management model for patients with severe acquired brain injury (... more

The denominator matters: Interpreting urinary albumin-to-creatinine ratio in older patients with heart failure

21 July 2026
Author(s): Fei Yang, Haoyang Hu

We read with great interest the study by Rubio-Gracia and colleagues examining the clinical and prognostic significance of the urinary albumin-to-creatinine ratio (UACR) in patients with heart... more

The challenge of innovation in lupus between abstraction and reality

20 July 2026
Author(s): Giuseppe A. Ramirez, Luca Moroni, Enrica P. Bozzolo, Marco Matucci-Cerinic, Lorenzo Dagna

“He that will not apply new remedies, must expect new evils.”Francis Bacon, Essays, “Of Innovations”, 1625.

In-flight human physiology at high-altitudes: not everyone should fly

18 July 2026
Author(s): Anna Teresa Mazzeo, Danilo Spanu, Deepak Gupta

Dear Editor,

Cultural congruence in mindfulness-based interventions for diabetes-related distress

18 July 2026
Author(s): Aamer Aldbyani

We read with interest the pilot study by Kortegaard et al. [1] on a group-based intervention targeting diabetes-related emotional distress among emerging adults with type 1 diabetes. While the study... more

Beyond comorbidities: Age as an independent predictor of survival in pulmonary arterial hypertension

17 July 2026
Author(s): Rafael Bravo-Marqués, Francisco Rivas-Ruiz, Eva Gutierrez-Ortiz, Isabel Blanco, Pilar Escribano-Subías

Dear Editor,

Reconsidering stepwise lipid-lowering titration and outpatient adherence dynamics after acute myocardial infarction

16 July 2026
Author(s): Hui Wang, Shuxiong Ge

We read with great interest the recent multicenter quality improvement audit by Gragnano and colleagues regarding diagnostic and therapeutic inertia in low density lipoprotein cholesterol management... more

Rethinking residual sex effects in frailty-adjusted ICU mortality

14 July 2026
Author(s): Jing Pang

Dankl et al. provide a valuable frailty-adjusted analysis of sex and 30-day mortality in older critically ill adults, and the combination of frequentist and Bayesian estimates is a particular... more

Interpreting the neutrophil-to-lymphocyte ratio in stable chronic obstructive pulmonary disease: Severity, case mix, and clinical utility

10 July 2026
Author(s): Kunlong Zhang, Xiaoqi Ying, Boxu Lang

We read with interest the retrospective study by Vanetti et al. [1], which evaluated the neutrophil-to-lymphocyte ratio (NLR) in 247 clinically stable patients with chronic obstructive pulmonary... more

Using latent class analysis for identifying clinical phenotypes associated with prognosis in patients with atrial high-rate episodes

3 July 2026
Author(s): Wenhui Li, Amir Askarinejad, Yanda Meng, Majid Haghjoo, Gregory Y.H. Lip, on behalf of The Liverpool AF Project Group

Atrial high-rate episodes (AHRE) detected by cardiac implantable electronic devices are frequently encountered in clinical practice [1,2] and are associated with an increased risk of atrial... more

Severe hyperkalaemia during liposomal amphotericin B treatment, independent of nephrotoxicity

2 July 2026
Author(s): C. Gourjault, T. Pietri, J. Carvelli, S. Ranque, N. Cassir

Dear Editor,

Artificial intelligence and clinical responsibility in the multimorbid patient

1 July 2026
Author(s): Domingo Ruiz-Hidalgo, Ramon Pujol Farriols, Roberto Elosua Llanos

Artificial intelligence (AI) is not simply transforming clinical practice; it is reshaping how clinical responsibility is organised. Much of the current debate has focused on whether AI will replace... more

Risk reclassification and implementation challenges in the 2026 AHA/ACC pulmonary embolism guideline

30 June 2026
Author(s): Nicola Mumoli, Lucia Colavolpe, Francesco Dentali

The recently published 2026 AHA/ACC guideline for the evaluation and management of acute pulmonary embolism (PE) introduces several conceptual innovations that may influence clinical practice beyond... more

Recurrent Pericarditis, Hydroxychloroquine, and the Unrecognized Risk of Myasthenia Gravis

30 June 2026
Author(s): Christian Messina

We read with great interest the article by Trotta et al. evaluating the role of hydroxychloroquine (HCQ) in recurrent pericarditis (RP), as well as the accompanying commentary by Tan et al. [1,2].... more

Obstructive sleep apnea syndrome as the missing piece in the puzzle of cardiovascular–kidney–liver–metabolic syndrome

29 June 2026
Author(s): Dimitrios Patoulias, Caterina Conte, Alexandra Kautzky-Willer

Dear Editor, the staging framework of cardiovascular–kidney–metabolic (CKM) syndrome initially proposed by the American Heart Association in November 2023 represents an impressive conceptual advance... more

Considerations regarding the diagnosis of short telomere syndrome in a patient with opportunistic infections

28 June 2026
Author(s): Salvatore Chirumbolo

The recent manuscript by Belhabib et al., presents an interesting and educational case of opportunistic infections associated with severe CD4+ lymphocytopenia, yet the central conclusion, that the... more

Interpreting echocardiographic improvement in EGPA: pulmonary vascular reversal, cardiac involvement, or disease activity?

28 June 2026
Author(s): Enmanuel A. Leiva-Murillo, Oriol Ventosa-Blázquez

We read with interest the study by Carlucci et al., “Eosinophil-linked pulmonary circulation in EGPA Improves under anti-IL-5/R therapy: A longitudinal study” [1]. The authors should be commended for... more

The missing piece in severe acquired brain injury care: Integrating neurophysiological screening for critical illness polyneuropathy and myopathy

18 June 2026
Author(s): Christian Messina

We read with great interest the recent article by Grifoni and Bucciardini, regarding the implementation of an interdisciplinary co-management model between the Neuro-Intensive Care Unit (Neuro-ICU)... more

Logistic regression ignores time-to-event in competing risks analysis

16 June 2026
Author(s): Zheqi Zhang, Zaiyou Qian, Jing Ma

We read with interest the study by Brunetti et al. on oral anticoagulant (OAC) nonprescription in older atrial fibrillation patients with reduced expected survival [1]. The authors should be... more

Readmission risk after protected discharge: are multidimensional tools superior to functional scales?

16 June 2026
Author(s): Gianluca Azzellino, Patrizia Vagnarelli, Ernesto Aitella, Lia Ginaldi, Massimo De Martinis

Early hospital readmissions remain one of the major challenges for healthcare systems and are widely recognized as an indicator of healthcare quality, effective discharge planning, and continuity of... more

Optical coherence tomography angiography in systemic sclerosis: from a microvascular signal to clinical utility

15 June 2026
Author(s): Shinya Yamaguchi, Shizuka Yamamoto, Rindai Saito, Hiroshi Ito

Comment on.

Baseline or dynamic prediction after venous thromboembolism? Clarifying the clinical use of the CAVE score for occult cancer

15 June 2026
Author(s): Hongquan Xing, Xiaoqun Ye

Jara-Palomares and colleagues should be congratulated for developing and externally validating an international score to estimate the risk of cancer within one year after venous thromboembolism (VTE... more

The time has come for comprehensive geriatric assessment in internal medicine

12 June 2026
Author(s): Chiara Ceolin, Marina De Rui, Sandro Giannini, Paolo Simioni, Giuseppe Sergi

Complexity has become a defining feature of modern internal medicine. Older adults with multimorbidity, polypharmacy, biological and functional vulnerability, and multidimensional frailty now... more

GLP-1 receptor agonists for the management of obesity in individuals treated with antipsychotics

2 June 2026
Author(s): Dimitrios Patoulias, Eleftherios Teperikidis, Michail-Angelos Mourtzos, Theocharis Koufakis, Paschalis Karakasis

Individuals with psychotic disorders treated with antipsychotic drug classes are at high risk for developing overweight/obesity and related cardiometabolic complications, resulting in excess... more

Reporting clinical escalation in Hospital-at-Home: from a single rate to a structured framework

29 May 2026
Author(s): David Nicolás, Andrea Parra-Plaza, Ainoa Ugarte

Hospital-at-Home (HaH) programmes are expanding rapidly across European health systems as substitutive acute care models [1,2]. As they consolidate, unplanned transfer back to hospital — termed... more

Microplastics in drinking water: A silent threat amplifying health inequities in low-resource settings

22 May 2026
Author(s): Mohamed Daud Mohamed, Liibaan Abdulahi Sudi, Abdikadir Ahmed Hassan, Iqro Omar Ibrahim, Yakub Burhan Abdullahi

Microplastics have become ubiquitous contaminants in global drinking water supplies. Detected in tap water, bottled water, and untreated sources across both high- and low-income countries, these... more

Male hypogonadism and incretin therapy response

22 May 2026
Author(s): Sandro La Vignera, Rosita A. Condorelli

Dear Editor,

Coronary microvascular dysfunction as a plausible convergent mechanism in cancer therapy-related MINOCA: evidence synthesis and a call for diagnostic standardization

18 May 2026
Author(s): Fuad A. Abdu

Myocardial infarction with non-obstructive coronary arteries (MINOCA) accounts for 6–10 % of all acute myocardial infarctions (MI), carries a non-trivial long-term risk of major adverse... more

Initial misdiagnoses in Sjögren’s disease patients

14 May 2026
Author(s): Adrian Y.S. Lee

Sjögren’s disease (SjD) is a chronic systemic autoimmune disease affecting exocrine glands, causing sicca symptoms, arthralgias and fatigue. It is highly heterogenous and may have variable clinical... more

Original Article

Circulating metabolites in adolescence associated with clinical obesity in young adulthood

2 November 2026
Author(s): Shinya Nakada, Ziyi Zhou, Carlos Celis-Morales, Jill P Pell, Frederick K Ho

In 2025, the Lancet Diabetes & Endocrinology Commission defined clinical obesity as excess body fat that is causing organ dysfunction, symptoms and physical limitations [1]. Unlike body mass... more

Cognitive impairment in uncontrolled vs controlled hypertension – systematic review and meta-analysis

30 October 2026
Author(s): Kinga Tyjas, Jakub Rusinek-Glück, Wiktoria Ziółek, Marek Rajzer, Aleksandra Gruszka-Gosiewska, Katarzyna Stolarz-Skrzypek

Hypertension is a well-recognized risk factor for the development of cognitive impairment (CImp) and brain vasculogenic lesions. The aim of this systematic review was to assess whether adequate blood... more

Recovery of worsening renal function after acute heart failure

28 October 2026
Author(s): Daniele Cocianni, Stefano Contessi, Maria Perotto, Davide Barbisan, Jacopo Giulio Rizzi, Giulio Savonitto, Elisa Soranzo, Enrico Brollo, Mattia Biber, Marco Merlo, Marco Masè, Massimo Imazio, Gianfranco Sinagra, Davide Stolfo

Worsening renal function (WRF) is common during hospitalization for acute decompensated heart failure (ADHF). However, the post-discharge trajectory of renal function in these patients remains... more

Assessment of serum micronutrient concentration in chronic pancreatitis: insights from the nationwide COMBO randomised trial,

17 October 2026
Author(s): NDE Thierens, FEM de Rijk, S Bai, PJ van der Schaar, RP Voermans, LM Kager, MM Tielemans, HS Pauw, CL van Veldhuisen, MG Besselink, PJF de Jonge, HC van Santvoort, JE van Hooft, MJ Bruno, JPH Drenth, RC Verdonk, on behalf of the Dutch Pancreatitis Study Group

In patients with chronic pancreatitis (CP), pancreatic exocrine insufficiency (PEI) and poor dietary intake may cause malnutrition. International guidelines recommend monitoring key micronutrients (... more

Phenotypes of diabetic kidney disease and cardiovascular outcomes

8 October 2026
Author(s): Sophie E Claudel, Runqi Zhao, Insa M Schmidt, Petter Bjornstad, Anand Srivastava, Sushrut S Waikar, Ashish Verma

To quantify the association between diabetic kidney disease (DKD) phenotypes and cardiovascular disease (CVD) mortality and incident major adverse cardiovascular events (MACE), atrial fibrillation (... more

Receptivity and susceptibility to care models for Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) in Europe: a mixed-methods, landscaping study

8 October 2026
Author(s): Leonard D. Broekman, Kirsi M.A. van Eekhout, Sophie Porro, Laura A.M. Konings, Sofia Carvalhana, Ioanna P. Kalafati, Manuel Romero-Gómez, Luca Miele, Jörn M. Schattenberg, Manuel Castro Cabezas, Jean W. Muris, Juan M. Mendive, Ghislaine J.M.W. van Thiel, Luisa Vonghia, Sven M. Francque, Maarten E. Tushuizen, Adriaan G. Holleboom, on behalf of the GRIPonMASH Consortium

Metabolic dysfunction-associated steatotic liver disease (MASLD), including metabolic dysfunction-associated steatohepatitis (MASH) and its fibrotic and cirrhotic stages, poses a growing burden on... more

External validation of the SHARPEN score for predicting in-hospital mortality in infective endocarditis

6 October 2026
Author(s): Mohammad Said Ramadan, Lorenzo Bertolino, Anna Maria Carolina Peluso, Oriana Infante, Nathalie Scarpulla, Iolanda Cafarella, Fabian Patauner, Emanuele Durante-Mangoni

Risk stratification of infective endocarditis (IE) using IE-specific variables remains limited. In this study, we evaluated SHARPEN in an Italian cohort and performed an exploratory paired comparison... more

Implementation of guideline-directed cardioprotective therapy in patients living with type 2 diabetes in outpatient cardiology ambulatory setting: the Italian CardioMET registry

5 October 2026
Author(s): Paola Gargiulo, Federica Marzano, Laura Liccardi, Savina Nodari, Matteo Cameli, Francesco Giallauria, Federico Guerra, Egidio Imbalzano, Gianfranco Sinagra, Stefano Carugo, Carmine Pizzi, Francesco Cipollone, Francesco Grigioni, Saverio Muscoli, Alberto Polimeni, Pasquale Perrone Filardi, on behalf of the CardioMET investigators

To assess the implementation of guideline-directed glucose-lowering therapies with proven cardiovascular (CV) benefit in individuals with type 2 diabetes mellitus (T2DM) attending Italian outpatient... more

Statins are associated with decreased risk of disease progression and death in non-cirrhotic patients with primary biliary cholangitis

3 October 2026
Author(s): Eirini I. Rigopoulou, Vasiliki Lygoura, Konstantinos Papantoniou, Stella Gabeta, Anna Samakidou, Dafni Sveroni, George Giannoulis, Nikolaos Gatselis, Kalliopi Zachou, Christos Triantos, George N. Dalekos

We evaluated whether statins in non-cirrhotic patients with primary biliary cholangitis (PBC) might influence disease progression, including cirrhosis development, hepatic decompensation, all-cause... more

Unsupervised clustering of undifferentiated systemic autoinflammatory diseases (USAID)

30 September 2026
Author(s): Jeanne Chauffier, Samuel Deshayes, Marion Delplanque, Philippe Mertz, Guilaine Boursier, Laurence Cuisset, Irina Giurgea, Laure Calas, Farah Bejar, Antoine Fayand, Gilles Grateau, French USAID Study Group, Léa Savey, Sophie Georgin-Lavialle

Autoinflammatory diseases induce recurrent systemic inflammatory attacks—often accompanied by fever—that occur independently of infectious triggers [1]. In daily practice, a major challenge arises... more

Respiratory-hypoxic burden and multimorbidity-related vulnerability are distinct dimensions of obstructive sleep apnea: A retrospective cohort analysis

29 September 2026
Author(s): Giada Gironda, Giulia Sartori, Alberto Fantin, Nadia Castaldo, Ernesto Crisafulli

Obstructive sleep apnea (OSA) is a heterogeneous disorder in which conventional apnea-hypopnea index (AHI)-based severity classification incompletely captures respiratory burden, nocturnal hypoxemia... more

European practices for screening and follow-up in mixed connective tissue disease: a survey of clinicians from the European Federation of Internal Medicine and ERN ReCONNET

25 September 2026
Author(s): Kevin Chevalier, Marie-Elise Truchetet, Cloé Comarmond, Jeska de Vries-Bouwstra, Voon Ong, Paola Triggianese, Diana Marinello, Marta Mosca, Silvia Bellando Randone, Sergio Prieto-González, Zana Brkic, Vera Guimarães, Magdalena Ciupera, Marzena Olesinska, Luc Mouthon, Benjamin Chaigne, on behalf of the European Federation of Internal Medicine Diseases Systemic Autoimmune Diseases working group and the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Mixed connective tissue group

Mixed connective tissue disease (MCTD) is a rare systemic autoimmune disorder defined by the co-occurrence of clinical features overlapping with other connective tissue diseases (CTD) such as... more

DEED-FRAIL trial: A cluster-randomized trial of a frailty-oriented multicomponent ED discharge intervention for older adults with geriatric vulnerability and acute heart failure

25 September 2026
Author(s): Francisco Javier Martín-Sánchez, Ana Suero Roiz, María Suárez Cadenas, Patricia Parra Esquivel, Begoña Espinosa, María Pilar López Díez, Rodolfo Romero Pareja, Miguel Alberto Rizzi Bordigoni, Carlos Bibiano, Javier Jacob, Enrique Martín Mojarro, Alfons Aguirre, Pere Llorens, Pablo Herrero, Esther Rodríguez Adrada, Cristina Bermejo Boixareu, Xavier Rosselló, Òscar Miró, DEED-Frail Trial Study Group

Heart failure (HF) is a common chronic condition characterized by progressive cardiovascular and global functional decline, often punctuated by recurrent episodes of decompensation that accelerate... more

Circulating angiogenic and inflammatory biomarkers profiling in patients with hereditary hemorrhagic telangiectasia

23 September 2026
Author(s): Bernat Villanueva, Agnès Figueras, Raquel Torres-Iglesias, Miriam Muñoz, Leticia-Ainhoa Sanz-Astier, Alfredo Martínez, Laura Ochoa-Callejero, Jesús Ribas, Francesc Viñals, Gael Genet, Antoni Riera-Mestre

Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disease (ORPHA:774), with an estimated prevalence of approximately 1 in 5000 individuals, and is considered the second most common... more

Hypertonic saline and high-dose furosemide in very elderly patients hospitalized for acute heart failure: A real-world cohort study

21 September 2026
Author(s): Guillermo Ropero-Luis, María Eugenia Carmona-Moreno, Marina Melgar-Velasco, José María González-Miret, Francisco José Guerrero-Márquez

The combination of hypertonic saline solution (HSS) and high-dose furosemide may enhance diuretic response in acute heart failure (AHF), but evidence in real-world populations, particularly very... more

Central embolic localization in acute pulmonary embolism: Prognostic marker or target for intervention?

21 September 2026
Author(s): Maria Cristina Vedovati, Ludovica Anna Cimini, Iolanda Enea, Manuela Romei, Giulio Righini, Giuseppe Pio Martino, Paola Mogni, Edoardo Pennacchio, Natale Vazzana, Annamaria Dachille, Giuseppe Francesco Fuscaldo, Francesco Di Filippo, Chiara Angotti, Donata Lucci, Cecilia Becattini, on behalf of COPE Investigators

In clinical practice, and in accordance with international guidelines, computed tomography pulmonary angiography (CTPA) is currently the gold-standard imaging test for diagnosing acute pulmonary... more

Modified Sequential Organ Failure Assessment score for prehospital critical care: defining thresholds and clinical implications

19 September 2026
Author(s): Carlos del Pozo Vegas, Juan F. Delgado Benito, Raúl López-Izquierdo, Isabel de la Torre, Erik Alonso, Santos Gracia Villar, Luis Alonso Dzul López, Rubén Calderón Iglesias, Agustín Mayo Íscar, Michael Eichinger, Ancor Sanz-García, Francisco Martín-Rodríguez

The modified Sequential Organ Failure Assessment (mSOFA) score demonstrates excellent discrimination for short-term mortality in prehospital settings; however, actionable risk stratification... more

Circulating Growth Hormone-Releasing Hormone Increases After Kidney Transplantation and Shows Divergent Associations with Gut-Derived Uremic Toxins

11 September 2026
Author(s): Camillo Tancredi Strizzi, Leah Hernandez, Samsul Arefin, Vincenzo Cantaluppi, Francesco Pesce, Peter Stenvinkel, Karolina Kublickiene

The growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis is disrupted in chronic kidney disease (CKD), yet its upstream regulator, growth hormone–releasing hormone (GHRH), has never been... more

Sex differences in triage priority, predictors, and outcomes in consecutive emergency department patients with chest pain

4 September 2026
Author(s): E Fanelli, P Bima, JS Boeddinghaus, L Crisanti, G Labarile, P Nazerian, E Pivetta, C Mueller, E Lupia, F Morello

Chest pain (CP) is a common reason for Emergency Department (ED) presentation and may signal life-threatening cardiovascular emergencies (CVE). Sex-related differences in CP management are... more

Phenotypic clustering and ABC pathway adherence in patients with atrial fibrillation at high risk of bleeding and stroke: Insights from three global registries

30 August 2026
Author(s): Amir Askarinejad, Tommaso Bucci, Enrico Tartaglia, Andrea Galeazzo Rigutini, Michele Rossi, Hung-Fat Tse, Majid Haghjoo, Giuseppe Boriani, Tze-Fan Chao, Gregory Y.H. Lip

Patients with atrial fibrillation (AF) who are at increased risk of both thrombotic and haemorrhagic events represent a heterogeneous and broad clinical entity, characterized by the presence of... more

Long-term vascular outcomes and biological predictors of thrombosis in systemic lupus erythematosus: a 10-year prospective cohort study

28 August 2026
Author(s): Leyre Riancho-Zarrabeitia, Nuria Vegas-Revenga, Lucía Domínguez-Casas, Alfonso Corrales, Carmen Bejerano, Iñigo Gonzalez-Mazón, Alex GarcíaTellado, Carmen Valero, José L Hernández, Ricardo Blanco

Systemic lupus erythematosus (SLE) is associated with increased cardiovascular morbidity, but the long-term prognostic value of subclinical atherosclerosis and circulating biomarkers remains... more

Recurrent venous thromboembolism and bleeding during anticoagulation in patients with deep-vein thrombosis treated with vitamin K antagonists or direct oral anticoagulants: insights from the RIETE registry

28 August 2026
Author(s): Paolo Prandoni, Raffaele Pesavento, Franca Bilora, Benjamin Brenner, Iria Francisco, Germán Sierra-Palomares, Ángeles Fidalgo, Jana Hirmerova, Samuel Fonseca, Manuel Monreal, the RIETE Investigators

Randomized trials have shown that direct oral anticoagulants (DOACs) are as effective as vitamin K antagonists (VKAs) for treating venous thromboembolism (VTE), with less major bleeding. Whether... more

Steroid-sparing biologics in severe asthma and chronic obstructive pulmonary disease: a systematic review, cross-disease meta-analysis, and translational estimate of corticosteroid-related harm prevented

24 August 2026
Author(s): Pier-Valerio Mari, Lorenzo Carriera, Angelo Coppola, Davide Onofrio Fontana, Simone Ielo, Alberto Ricci, Veronica Ojetti, Umberto Semenzato, Francesco Menzella, Stefano Baglioni, Cecilia Becattini, Eugenio De Corso

Oral corticosteroids (OCS) remain widely used in uncontrolled severe asthma and frequently exacerbating chronic obstructive pulmonary disease (COPD), but cumulative exposure is associated with dose-... more

Effects of bariatric surgery on apolipoprotein A1, apolipoprotein B, and apolipoprotein B/ apolipoprotein A1 ratio: Findings from a prospective cohort

22 August 2026
Author(s): José Ignacio Martínez-Montoro, Alba Rodriguez-Muñoz, Mario Gutiérrez-Bedmar, Nerea Ruiz-Campos, Luis Ocaña-Wilhelmi, Diego Fernández-García, Juan Manuel Blanco-Millán, Ángela Núñez-Morales, Dieter Morales-García, Francisco J. Tinahones, Lourdes Garrido-Sánchez, Carolina Gutiérrez-Repiso

Bariatric surgery is associated with significant improvements in cardiometabolic health. The apolipoprotein B (ApoB)/apolipoprotein A1 (ApoA1) ratio has been demonstrated to be a strong predictor of... more

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study

21 August 2026
Author(s): Wiessam Abu Ahmad, Yael Wolff Sagy, Ronen Arbel, Erez Battat, Dror Dicker, Gil Lavie, Orna Reges

This study evaluates dementia and Parkinson's disease (PD) risk among patients with type 2 diabetes (T2D) and obesity initiating GLP-1 receptor agonists (GLP-1 RAs) compared with other oral glucose-... more

Sex-specific differences in the clinical and psychiatric phenotype of hospitalized patients admitted to a tertiary alcohol-related disease unit

13 August 2026
Author(s): Margherita Vergadoro, Chiara Ceolin, Simona Di Liberto, Giovanni Gottardi, Benedetta Perotti, Anna Franceschini, Luca Fabris, Luca Spiezia, Erika Zola, Paolo Simioni

Alcohol Use Disorder (AUD) is a chronic disease characterized by impaired control over alcohol intake, cravings, and continued use despite physical, psychological, and social consequences [1].

Hospitalisation and healthcare use in persons screened for atrial fibrillation compared with usual care

13 August 2026
Author(s): Emilie Katrine Kongebro, Christian Kronborg, Thomas Clement Truelsen, Ketil Jørgen Haugan, Claus Graff, Søren Højberg, Axel Brandes, Lars Køber, Christian Torp-Pedersen, Jesper Hastrup Svendsen, Søren Zöga Diederichsen

The impact of screening for incident atrial fibrillation (AF) on healthcare use and hospitalisation is largely unknown.

“Hospital-at-home and 30-day readmission among clinically eligible patients: a prospective cohort study with a capacity-constrained comparator group”

11 August 2026
Author(s): Pablo Rodríguez-Cortés, Elena Arranz Canales, Alexia Constanza Espiño Álvarez, Javier Bernardo Pérez-Serrano, Laura Rabes-Rodríguez, Marta Fernández Rico, Eva María Fernández Bermejo, Ángela Sánchez Juez, Victoria Gutiérrez Gómez-Lus, Fernando Ruiz Berraco, Saida Alonso Marrero, Jaime Bustos Carpio, Carmen Sáez Béjar, José María Galván-Román, Fernando Sebastian-Valles

To evaluate the association between hospital-at-home (HaH) care and unplanned 30-day hospital readmission using a capacity-based comparator group of clinically eligible patients admitted to... more

Prevalence and incidence of diabetes in patients with non-functional adrenal tumors

11 August 2026
Author(s): Fredrik Sahlander, Ana Carasel, Buster Mannheimer, Jonatan D. Lindh, Henrik Falhammar

The association between non-functional adrenal tumors (NFAT) and diabetes is unclear.

Deprescribing of blood pressure-lowering medications in patients with hypotensive syncope

11 August 2026
Author(s): Vincenzo Russo, Erika Parente, Angelo Comune, Antonella Groppelli, Jaume Francisco-Pascual, Nuria Rivas-Gándara, Jean-Claude Deharo, Baptiste Maille, Frederik J. De Lange, Thomas T. Boel, Giulia Rivasi, Mattia Laffi, Roberto Maggi, Rose Anne Kenny, Artur Fedorowski, Gianfranco Parati, Michele Brignole

The hypotensive phenotype of autonomic syncope is characterized by hypotension as the predominant hemodynamic mechanism underlying loss of consciousness [1,2]. The term hypotensive phenotype... more

Prevalence of orthostatic hypotension in heart failure: a systematic review and meta-analysis

4 August 2026
Author(s): Federica Coscetta, Bernadette Corica, Andrea De Mare, Valeria De Grazia, Giordana Iannibelli, Stefano Negri, Francesco Murru, Andrea Salzano, Antonio Cittadini, Marco Proietti, Alberto Maria Marra

Orthostatic hypotension (OH), defined as a reduction in systolic/diastolic blood pressure ≥20/10 mmHg upon standing, is common in older adults and may interfere with the optimization of guideline-... more

Educational professional activities for enhancing heart failure guidelines implementation: data from the Optimization of Therapy in the Italian Management of Heart Failure (OpTIMa-HF) Registry

4 August 2026
Author(s): Stefania Paolillo, Federica Marzano, Dario Bruzzese, Gennaro Galasso, Franco Guarnaccia, Giosuè Santoro, Paolo Severino, Piergiuseppe Agostoni, Savina Nodari, Federico Guerra, Paolo Calabrò, Gianfranco Sinagra, Roberta Montisci, Giuseppe Patti, Michele Senni, Pasquale Perrone Filardi, on behalf of the OpTIMa-HF Investigators

European guidelines recommend for heart failure with reduced ejection fraction (HFrEF) rapid initiation and later up-titration of four foundation drugs. We assessed whether an educational... more

Cardiac rehabilitation referral and access by country income class: Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation’s 2025 Global Audit Update

31 July 2026
Author(s): Rachael P. Carson, Sherry L. Grace, Karam Turk Adawi, Mariya P. Jiandani, Lilian Mbau, Jimena Martinez, Monserrat Cruz Rivero, Claudia V. Anchique, Rongjing Ding, Dinah L. van Schalkwijk, Jonathan Gallagher, Won-Seok Kim, Pamela Seron, Lela Maskhulia, Emil Hagström, Arto Hautala, Yoshihiro Fukumoto, Gabriela L.M. Ghisi

To characterize CR: (1) referral practices, (2) systematic referral barriers, (3) wait listing, (4) program-level approaches to mitigating patient access barriers, as well as (5) CR reimbursement... more

Biological therapy in Takayasu arteritis. Results from the REVAS registry

30 July 2026
Author(s): J Mestre-Torres, JL Callejas-Rubio, M Pérez-Conesa, B de Escalante-Yangüela, A Núñez-Conde, F Martínez-Valle, EM Fonseca-Aizpuru, R Solans-Laqué

Biological therapy in patients with Takayasu arteritis is frequently used, but the factors associated with its use have not been determined. The present study aims to describe and identify predictors... more

Exercise-based prehabilitation programs reduce hospital stay and postoperative complications in surgical patients with cancer: a systematic review and meta-analysis

29 July 2026
Author(s): Manuel Fernandez-Escabias, Sofia Carrilho-Candeias, Cristian Garcia-Sanchez, Andrea Orellana-Jaen, Alberto Millan-Martin, Almudena Carneiro-Barrera, Jonatan R Ruiz, Francisco J Amaro-Gahete

Cancer prevalence and mortality rates are rapidly increasing worldwide, making it a leading cause of morbidity and death [1]. Although surgery is considered the primary treatment for most cancers [2... more

The cardio-hepatic syndrome and right ventricular dysfunction in heart failure with mildly reduced ejection fraction

24 July 2026
Author(s): Tobias Schupp, Henning Johann Steffen, Noah Abel, Alexander Schmitt, Marielen Reinhardt, Felix Lau, Michelle Goertz, Jonas Dudda, Kathrin Weidner, Mohammad Abumayyaleh, Jonas Rusnak, Michael Behnes, Ibrahim Akin

Right ventricular dysfunction (RVD) is common in patients with heart failure (HF) and reduced ejection fraction and may lead to cardio-hepatic syndrome (CHS). The present study investigates the... more

Weight-adjusted fluid balance and its impact on days alive without life support in critical illness – an observational cohort study

23 July 2026
Author(s): Debora M. Hofer, Mathieu Pitteloud, Martin Faltys, Alessandro Ostini, Jan Waskowski, Anna S. Messmer, Carmen A. Pfortmueller

In the last decade, intravenous fluid therapy in critically ill patients and its adverse side effects have received increasing attention. The total of resuscitation fluids, maintenance fluid therapy... more

Subclinical hypotension in acute decompensated heart failure: prognosis and treatment implementation

21 July 2026
Author(s): Giulio Savonitto, Davide Stolfo, Mattia Emanuele Biber, Daniele Cocianni, Stefano Contessi, Maria Perotto, Jacopo Giulio Rizzi, Elisa Soranzo, Marco Masè, Marco Merlo, Gianfranco Sinagra

Patients hospitalized for acute decompensated heart failure (ADHF) with low blood pressure (BP) represent a clinically challenging yet frequently encountered subgroup in daily practice [1,2].... more

Impact of ECOG performance status on cancer-associated thrombosis treated with DOACs: Data from a multicenter cohort study

16 July 2026
Author(s): Rosa Talerico, Francesco Mancinetti, Clara Sacco, Matteo Mazzetti, Elena Campello, Simone Birocchi, Sofia Beccatini, Angelo Porfidia, Corrado Lodigiani, Paolo Simioni, Gian Marco Podda, Isabella Mastandrea, Cecilia Becattini, Roberto Pola, Maria Cristina Vedovati

Data on safety and effectiveness of direct oral anticoagulants (DOACs) in patients with cancer-associated thrombosis (CAT) and impaired functional status are limited. We evaluated the impact of... more

non-HDL-C: The missing parameter in primary care

16 July 2026
Author(s): Carlos Baeza-Delgado, Inma Sauri, Javier Diaz, Antonio Fernandez, Maria Jose Forner, Fernando Martinez, Sergio Martinez, Josep Redon

Lipid assessment forms part of routine healthcare assessments of the general population, primarily to identify the risk of atherosclerotic cardiovascular disease (ASCVD). It is recommended that these... more

Adipose tissue and adherence to the Mediterranean diet: Key factors for sleep quality in Polyendocrine Metabolic Ovarian Syndrome (PMOS)?

11 July 2026
Author(s): Ludovica Verde, Martina Galasso, Annamaria Colao, Luigi Barrea, Giovanna Muscogiuri

Sleep disturbances are common findings in women with Polyendocrine Metabolic Ovarian Syndrome (PMOS), though mechanisms remain unclear. This observational case-control study aimed to identify... more

Clinical and prognostic significance of urinary albumin-to-creatinine ratio in heart failure: insights from the RICA-2 registry

10 July 2026
Author(s): Jorge Rubio-Gracia, Marta Sánchez-Marteles, Beatriz Seoane, Iria Rodríguez, Jose Manuel Cerqueiro, Ana Suárez-Lombraña, Cristina Sánchez-Sánchez, Ivan Suárez-Pereira, Jose Pérez-Silvestre, Joan Carles Trullas

Heart failure (HF) is frequently accompanied by renal dysfunction and systemic congestion, reflecting the complex interaction between the heart and the kidneys within the cardiorenal syndrome. The... more

Diagnosis, treatment and outcomes of euvolemic hyponatremia among geriatric hospitalised patients

4 July 2026
Author(s): Damiano Astolfi, Jonathan Dash, Antonio Leidi, Véronique Trombert, Christophe Graf, Sandra De Breucker

Hyponatremia is the most common electrolytic disturbance among inpatients. It is associated with poor outcomes in frail older patients, even for mild disturbances. Prevalence increases with age, and... more

Sex-based differences and clinical outcomes in older adults with Candida bloodstream infection: a post-hoc secondary analysis of a multicentre study

3 July 2026
Author(s): Claudia Bartalucci, Jon Salmanton-García, Giusy Tiseo, Marco Falcone, Marco Muccio, Laura Caldararo, Daniele Roberto Giacobbe, Luca Bucci, Jesus Guinea, Malgorzata Mikulska, Maricela Valerio, Emilio Bouza, Patricia Muñoz, Jordi Rello, Matteo Bassetti, Antonio Vena, ESCMID Fungal Infection Study Group (EFISG) and ESCMID Study Group for Infections in the Elderly (ESGIE)

Candida bloodstream infections (BSI) are a major cause of disease in hospitalized patients, with particularly high morbidity and mortality among older adults. However, the impact of biological sex on... more

Low-renin hypertension in incidental adrenal adenomas and response to aldosterone-targeted therapy: a prospective study

27 June 2026
Author(s): Thomas Uslar, Benjamín Sanfuentes, Roberto Olmos, Alberth Burnier, Pauline Böhm, Francisco J. Guarda, Álvaro Huete, Nicolás Mertens, Cecilia Besa, Marcelo Andía, Alejandro Majerson, Jaime Cartes, Alejandra Tapia-Castillo, Cristian A. Carvajal, Carlos E. Fardella, Fidel Allende, Sandra Solari, Anand Vaidya, Rene Baudrand

Incidental adrenal adenomas are common, yet renin status is infrequently assessed in hypertensive patients. Emerging evidence supports a spectrum of renin-independent aldosterone excess associated... more

Pharmacokinetic robustness of direct oral anticoagulants vs. phenprocoumon in the emergency setting: impact of renal and hepatic impairment

27 June 2026
Author(s): Fatma Merzou, Luca Tarantini, Benjamin Landau, Martin Lesmeister, Hanna Martin, Thomas Bertsch, Shrey Mathur, Sergiu Groppa, Yaroslav Winter, Klaus Fassbender, Piergiorgio Lochner

Direct oral anticoagulants (DOACs) are increasingly used, but their pharmacokinetic stability compared to vitamin K antagonists during acute illness remains poorly characterized. We aimed to evaluate... more

SARS-CoV-2 infection, viral burden, and variant-specific outcomes in hospitalized patients with heart failure

24 June 2026
Author(s): Mohamad Amer Nashtar, Mohammed Salemdawod, Haris Sehovic, Gizem Garipoglu, Betül Ödemis, Asterios Tzalavras, Martin Steinmetz, Ali Canbay, Mustafa Özçürümez, Varnavas Varnavas, Polykarpos Christos Patsalis, Antonios Katsounas

Patients with heart failure (HF) are particularly vulnerable to systemic infection; however, the combined impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral... more

Eosinophil-linked pulmonary circulation in EGPA Improves under anti-IL-5/R therapy: A longitudinal study

19 June 2026
Author(s): Palma Carlucci, Marialuisa Sveva Marozzi, Francesco Corvasce, Silvia Noviello, Federico Spataro, Vanessa Desantis, Monica Montagnani, Roberto Ria, Sebastiano Cicco, Angelo Vacca

Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare, multisystemic vasculitis that primarily affects small to medium-sized blood vessels. It is characterized by a well-defined triad of... more

Vitamin D at hospital admission as an independent predictor of outcome of sepsis patients: Results of a secondary analysis from a “Need-Speed” trial prospective cohort

19 June 2026
Author(s): Pier Paolo Sainaghi, Manuela Rizzi, Stelvio Tonello, Federica Vincenzi, Marco Primatesta, Umberto Dianzani, Roberta Rolla, Paolo Amedeo Tillio, Mario Pirisi, Enrico Lupia, Francesco Franceschi, Salvatore Di Somma, Maria Lorenza Muiesan, Gianni Biolo, Gian Carlo Avanzi, Luigi Castello, Delivida-NeedSpeed Study Group

Sepsis is currently defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection, according to the Sepsis-3 consensus [1].

Depressive symptoms in older patients undergoing electrical cardioversion of persistent atrial fibrillation. A possible association with clinical complexity, physical performance and inflammation

18 June 2026
Author(s): Stefano Fumagalli, Michele Biagioli, Marta Niccolini, Arianna Tariello, Elisa Berni, Domenico Davino, Veronica De Angelis, Emanuele Santamaria, Alessandro Mengozzi, Claudia Di Serio, Giulia Spanalatte, Djullye Miduri Da Silva Nakano, Camilla Cagnoni, Denise De Grazia, Igor Diemberger, Agostino Virdis

Atrial fibrillation is the most frequently sustained arrhythmia diagnosed in older individuals. In 15 years, the prevalence of AF greatly increased in subjects ≥85 years approaching 40% [1]. The... more

Fibroblast growth factor 23 and mortality, heart failure and cardiovascular events across the chronic kidney disease spectrum - A systematic review and meta-analysis

13 June 2026
Author(s): Daniele Vetrano, Antonio De Pascalis, Alessandro Tomassetti, Giorgia Comai, Miriam Di Nunzio, Simona Barbuto, Gianfranco Sinagra, Gaetano La Manna, Giuseppe Cianciolo

Chronic kidney disease (CKD) is a highly prevalent condition worldwide and is associated with a substantial cardiovascular burden and premature mortality [1,2]. The risk of cardiovascular events and... more

How many blood eosinophil measurements are needed to identify COPD patients eligible for biologic therapy? A multi-source decision analysis simulation

12 June 2026
Author(s): Pier-Valerio Mari, Angelo Coppola, Simone Ielo, Raffaele Scala, Eugenio de Corso, Veronica Ojetti, Alberto Ricci, Stefano Baglioni, Lorenzo Carriera

Biologic therapies for eosinophilic COPD require a blood eosinophil count (BEC) ≥300 cells/µL for eligibility. Landmark trials used a single screening measurement, yet BEC exhibits substantial within... more

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease

11 June 2026
Author(s): Ana Serrano-Combarro, Belén Atienza-Mateo, Adrián Martín-Gutierrez, Libe Ibarrola Paino, Ivette Casafont-Solé, Jesús Loarce-Martos, Juan María Blanco-Madrigal, Rafaela Ortega-Castro, Natalia Mena-Vázquez, Carlos Fernández-Díaz, Javier Loricera, Diego Ferrer-Pargada, Iván Ferraz-Amaro, Santos Castañeda, Ricardo Blanco, Spanish Collaborative Group of Interstitial Lung Disease Associated with Rheumatoid Arthritis

ABA stabilised lung function, improved RA control, and reduced glucocorticoid use.Earlier initiation was associated with better DLCO preservation in adjusted analyses, suggesting a possible pulmonary... more

Cardiological hypertensive emergencies: Real word data compared to guidelines indications

9 June 2026
Author(s): Filippo Brucato, Chiara Tognola, Lorenzo De Censi, Elisa Andrian, Andrea Tacchetto, Beatrice Invernici, Sara D’alesio, Silvia Gheda, Nicolò Capsoni, Filippo Galbiati, Bombelli Michele, Cristina Giannattasio, Alessandro Maloberti

Hypertensive Emergencies (HE) are defined as a severe elevation in Blood Pressure (BP), i.e. higher than 180/120 mmHg, associated with the evidence of a new or worsening Hypertension Mediated Organ... more

Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: a pooled analysis of randomized trials

8 June 2026
Author(s): Pedro Marques, Francisco Vasques-Nóvoa, Mariana Pintalhão, Rui Bergantim, Luís Mendonça, João Sérgio Neves, Fernando Friões, Abhinav Sharma, Gerassimos Filipatos, Javed Butler, Stefan Anker, Faiez Zannad, Milton Packer, João Pedro Ferreira

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) increase hemoglobin and hematocrit, effects that have emerged as key statistical mediators of the cardiorenal benefits observed with SGLT2i... more

Recurrent t(9;12) translocation disrupting ACVRL1 intron 9 causes hereditary haemorrhagic telangiectasia missed by standard exome sequencing in four unrelated families

6 June 2026
Author(s): Anna Esteve-Garcia, Irene Madrigal, Cinthia Aguilera, Cristina Sau, Virginia Aquino, Joan Albert Barberà, Aurora Sánchez, Beatriz Morte, Laia Rodríguez-Revenga, María Isabel Alvarez-Mora, Jesus Ribas, Raquel Torres-Iglesias, Alejandro Portillo Medina, Antoni Riera-Mestre, Ariadna Padró-Miquel

Hereditary haemorrhagic telangiectasia (HHT) (MIM #187300, ORPHA:774), also known as Rendu-Osler-Weber disease, is a rare autosomal dominant vascular disorder and the second most common inherited... more

Phase III maintenance telerehabilitation in elderly patients with chronic heart failure and type 2 diabetes (TELEMECHRON study)

6 June 2026
Author(s): Simonetta Scalvini, Veronica Donati, Emanuela Zanelli, Vittorio Giudici, Luigina Viscardi, Salvatore D'Isa, Roberto Trevisan, Palmira Bernocchi

Heart failure (HF) and type 2 diabetes (T2DM) are significant public health concerns. This study evaluated a 6-month home-based telemedicine program for older patients with combined HF and T2DM. The... more

Sex and 30-day mortality in elderly critically Ill adults: A frailty-adjusted multinational analysis with frequentist and bayesian estimates

5 June 2026
Author(s): Daniel Dankl, Raphael Romano Bruno, Michael Beil, Hans Flaatten, Malte Kelm, Sviri Sigal, Wojciech Szczeklik, Muhammed Elhadi, Michael Joannidis, Andreas Koköfer, Barbara Schreiber, Franz Singhartinger, Sandra Oeyen, Brian Marsh, Rui Moreno, Susannah Leaver, Dylan W De Lange, Bertrand Guidet, Ariane Boumendil, Christian Jung, Bernhard Wernly

Evidence on sex-related mortality differences in critically ill older adults is inconsistent, and frailty is rarely incorporated despite its major prognostic relevance in geriatric intensive care.

Prevalence and impact of psychiatric and neurocognitive comorbidities on pulmonary rehabilitation outcomes

5 June 2026
Author(s): Michele Vitacca, Adriana Olivares, Roberta Borri, Valeria Torlaschi, Lidia Gazzi, Daniel Michael Portolani, Cinzia Lastoria, Simona Aggiato, Claudio Candia, Mauro Maniscalco, Giuseppina Cassetti, Martina Vigorè, Simona Merla, Gundi Steinhilber, Pasquale Moretta

Chronic respiratory diseases are associated with psychiatric/neurocognitive comorbidities; prevalence, clinical impact and responsiveness to in-patient pulmonary rehabilitation (PR) remain poorly... more

Pre-admission and in-hospital embolisms have a different prognostic significance in infective endocarditis

4 June 2026
Author(s): María de Miguel-Álava, Javier López, Isidre Vilacosta, Carmen Olmos, Carmen Sáez, Gonzalo Cabezón, Daniel Gómez Ramírez, Patricia Landín, Victoria Gutiérrez Gómez-lus, Adrián Lozano, Andrea Oña, Itziar Gómez-Salvador, J.Alberto San Román

To describe the clinical profile of a large cohort of patients with left-sided IE (LSIE) and embolic events (EE); to explore differences between those who present with an embolism at admission (EEa)... more

Innovative co-management between Neuro-ICU and Neurorehabilitation Unit in patients with severe acquired brain injury: enhancing clinical care pathways

30 May 2026
Author(s): Camilla Grifoni, Luca Bucciardini

Severe acquired brain injury (sABI) is a major challenge in post-acute care, affecting disability, quality of life, and healthcare resources. Traditional sequential care from acute units to... more

Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database

26 May 2026
Author(s): Blaž Burja, Marouane Boubaya, Cosimo Bruni, Lisa Christ, Lidia P. Ananyeva, Fabiola Atzeni, Christina Bergmann, Patricia E. Carreira, Jeska De Vries-Bouwstra, Nicoletta Del Papa, Antonella Marcoccia, Okada Masado, Gabriela Riemekasten, Edoardo Rosato, Tim Schmeiser, Marco Sprecher, Anna-Maria Hoffmann-Vold, Florian Kollert, Sabina Guler, Oliver Distler, Muriel Elhai, EUSTAR collaborators

In the large EUSTAR cohort, anti-Ro/SSA antibodies are detected in 15% of SSc patients and represent an independent risk factor for the presence and severity of ILD, particularly for cases with anti-... more

Exercise pulmonary hypertension in asymptomatic patients with HIV infection Insights from the RIGHT-NET registry

18 May 2026
Author(s): R Madonna, AM Marra, F Biondi, A Carbone, E Carluccio, V Codullo, M D’Alto, A D’Agostino, M De Luca, AM Esposito, F Ferrara, S Ghio, M Franzese, M Zanfardino, R Naeije, R De Caterina, E Bossone

Asymptomatic patients with Human Immunodeficiency Virus (HIV) infection may remain at increased risk for pulmonary vascular disease. We therefore explored the pulmonary circulation in these patients... more

Pulmonary artery dilation in pulmonary arterial hypertension: haemodynamic determinants and association with sudden death

15 May 2026
Author(s): Fabio Dardi, Federico Donato, Francesco Cennerazzo, Fabio Niro, Alberto Ballerini, Daniele Guarino, Vincenzo Russo, Riccardo Bertozzi, Elena Nardi, Alessandra Manes, Massimiliano Palazzini, Luigi Lovato, Nazzareno Galiè

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary vascular resistance and pressure, leading to right ventricular failure and reduced survival.... more

Sex-related disparities in sepsis in western Europe: A systematic review and meta-analysis

11 May 2026
Author(s): Hagar L. Mowafy, Nicolas Garin, Antonios Katsounas, Pere Castellvi, Jordi Rello, On behalf of ESGIE/ESGCIP study group investigators

Sepsis is a potentially fatal systemic disease characterized by dysregulated immune response to infection [1]. Despite significant improvements in early detection and management, sepsis continues to... more

Review Article

Exercise-induced epigenetic remodeling in COPD skeletal muscle dysfunction: From sedentary behavior to molecular rehabilitation

15 October 2026
Author(s): Salvatore Fuschillo, Claudio Candia, Andrea Motta, Mauro Maniscalco

Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a multisystem disorder in which extrapulmonary manifestations substantially contribute to disease burden. Among these,... more

Innovative holistic treatment for CKM: what lies ahead?

5 October 2026
Author(s): Paul Balfanz, Nikolaus Marx

Cardiovascular-kidney-metabolic (CKM) syndrome, as defined by the American Heart Association, encompasses interrelated metabolic, kidney, and cardiovascular disorders that mutually reinforce one... more

Gastrointestinal ultrasound in systemic sclerosis: A scoping review of current evidence

1 October 2026
Author(s): Chiara Calabrese, Corrado Campochiaro, Francesco Bonomi, Silvia Bellando Randone, Giulia Bandini, GIUSS Task Force

Systemic sclerosis (SSc) is a rare systemic autoimmune rheumatic disease frequently associated with gastrointestinal (GI) involvement. GI manifestations are heterogeneous, may occur throughout the... more

CKM: Epidemiology, current clinical implications and future burden

18 September 2026
Author(s): Elisa Russo, Miriam Dotta, Elisabetta Bussalino, Diego Moriconi, Francesca Viazzi

Cardiovascular–kidney–metabolic (CKM) syndrome was formalized by the American Heart Association in 2023 to capture the biological and clinical continuum linking excess adiposity, metabolic... more

Microvascular and macrovascular complications of diabetes in people with HIV

31 August 2026
Author(s): Maria Mazzitelli, Marco Zuin

Diabetes mellitus (DM) is increasingly prevalent in people with HIV, with reported prevalence estimates generally ranging from 5% to 15% across contemporary cohorts. It represents a major contributor... more

Sex and gender specific considerations on frailty: what have we learned?

11 August 2026
Author(s): Marzia Miglionico, Valentina Manzini, Giovanna Valentina Florelli, Giulio Francesco Romiti, Laura Bagnara, Stefania Basili, Marco Proietti, Valeria Raparelli

Aging entails a progressive impairment of functions and, ultimately, leads to increased susceptibility to disability, morbidity, and mortality. Around 85% of people aged more than 75 years suffer... more

Personalizing cardiovascular prevention in chronic kidney disease: an operational framework for risk-treatment mapping

11 August 2026
Author(s): Carmine Zoccali, Csaba P Kovesdy, Francesca Mallamaci, Navdeep Tangri, Vianda Stel, Nisha Bansal, Peter Stenvinkel, Kitty Jager

Patients with chronic kidney disease (CKD) bear a disproportionate burden of cardiovascular (CV) morbidity and mortality, yet preventive strategies in clinical practice remain remarkably conservative... more

Particle engineering, aerosol physics, and pulmonary deposition of single-inhaler triple ICS/LABA/LAMA therapies in obstructive airway diseases

1 August 2026
Author(s): Claudio Sorino, Johann Christian Virchow, Antonio Spanevello, Agata Buscemi, Fulvio Braido, Nicola Scichilone

Search Strategy

Sugar and artificial sweeteners and risk of cardiovascular disease

30 July 2026
Author(s): Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis, Antonis S. Manolis

Humans have an innate preference for sweetness; in this regard, dietary sugar consumption patterns are established early in life. Although moderate consumption of naturally occurring sugars from... more

Acute cardio-renal and Reno-Cardiac syndromes in critical care

29 July 2026
Author(s): Alessandro Girombelli, Yaroslava Longhitano, Francesco Vetrone, Roberto Vicinanza, Christian Zanza, “Cardiorenal Critical Care Coalition”

Cardiorenal syndrome (CRS) encompasses a spectrum of disorders in which acute or chronic dysfunction of the heart or kidneys are the key drivers of injury. CRS types 1 and 3 are the subtypes most... more

Alcohol withdrawal syndrome in hospitalized patients: a practical review

25 July 2026
Author(s): Fabio Caputo, Lisa Lungaro, Anna Costanzini, Roberto De Giorgio, Giovanni Addolorato

Alcohol withdrawal syndrome (AWS) develops in patients with alcohol use disorder (AUD) and physical dependence after abrupt cessation or substantial reduction of sustained heavy alcohol use. It is... more

Cardiovascular complications of antineoplastic treatment in prostate cancer patients and compensatory strategies for clinical management

1 July 2026
Author(s): Nikolaos Tsiamis, Fotios Toulgaridis, Eleni Stefanou, Christos Tountas, Georgios Tsitsinakis, Evangelos Ballas, Ioannis Maurogenis, Anastasia Kitsiou, Christo Kole

Prostate cancer (PCa) represents one of the most prevalent malignancies affecting men worldwide and constitutes a major public health challenge. According to the most recent GLOBOCAN estimates,... more

Understanding the Barriers to Translating Artificial Intelligence into the Clinical Laboratory

27 June 2026
Author(s): Michael Neale, Cynthia Wong, Daniel Kreuter, Joseph Taylor, Suthesh Sivapalaratnam

Artificial intelligence (AI) is having a transformational impact on society, yet its adoption in laboratory medicine has proceeded notably slower than in many other industries and even different... more

From technology adoption to noise reduction: Behavioral and psychological dimensions of clinical artificial intelligence deployment

19 June 2026
Author(s): Daniel Ostrovsky, Uriel Haran, Victor Novack

For more than five decades, patients with the same condition have received markedly different care depending on which clinician they happen to see. This unwarranted clinical variation has been... more

Artificial intelligence in cardiovascular care for internal medicine: from promising algorithms to useful clinical services

29 May 2026
Author(s): Louis-Marie Desroche, Antonin Trimaille, Benoît Lequeux, Nicolas Homehr, Nicolas Girerd

Cardiovascular disease is a core part of internal medicine, where clinicians manage patients with multimorbidity, polypharmacy, repeated transitions of care, and a high burden of fragmented... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness